Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.

MLA

Nakajima, Takahiro, et al. “Augmentation of Antibody-Dependent Cellular Cytotoxicity with Defucosylated Monoclonal Antibodies in Patients with GI-Tract Cancer.” Oncology Letters, vol. 15, no. 2, Feb. 2018, pp. 2604–10. EBSCOhost, https://doi.org/10.3892/ol.2017.7556.

APA

Nakajima, T., Okayama, H., Ashizawa, M., Noda, M., Aoto, K., Saito, M., Monma, T., Ohki, S., Shibata, M., Takenoshita, S., & Kono, K. (2018). Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer. Oncology Letters, 15(2), 2604–2610. https://doi.org/10.3892/ol.2017.7556

Chicago

Nakajima, Takahiro, Hirokazu Okayama, Mai Ashizawa, Masaru Noda, Keita Aoto, Motonobu Saito, Tomoyuki Monma, et al. 2018. “Augmentation of Antibody-Dependent Cellular Cytotoxicity with Defucosylated Monoclonal Antibodies in Patients with GI-Tract Cancer.” Oncology Letters 15 (2): 2604–10. doi:10.3892/ol.2017.7556.